Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study

Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study

Abstract Background Africa has some of the highest cervical cancer incidence and mortality rates globally. Burkina Faso launched a human papillomavirus (HPV) vaccination programme for 9-year-old girls in 2022 with support from Gavi, the Vaccine Alliance (Gavi). An economic evaluation of HPV vaccinat...

Full description

Bibliographic Details
Main Authors: Joël Arthur Kiendrébéogo, Annick Raissa O. Sidibe, Ghislain Bertrand Compaoré, Relwendé Nacanabo, Orokia Sory, Issa Ouédraogo, Saira Nawaz, Anne E Schuind, Andrew Clark
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Health Services Research
Subjects:
HPV vaccine
Economic evaluation
Cost-effectiveness
Modelling study
Burkina Faso
Online Access:https://doi.org/10.1186/s12913-023-10283-3

Internet

https://doi.org/10.1186/s12913-023-10283-3

Similar Items